Amylyx Pharmaceuticals, Inc. (AMLX) Insider Trading -- Recent Executive & Director Transactions

8 insiders reported 61 Form 4 transactions for Amylyx Pharmaceuticals, Inc. (AMLX) over the past 18 months (most recent 2026-08-20). Recent activity: FRATES JAMES M (Chief Financial Officer) Buy 22,807 shares, Bedrosian Camille L (Chief Medical Officer) Buy 22,807 shares, Klee Justin B. (Co-Chief Executive Officer) Buy 60,039 shares, Cohen Joshua B (Co-Chief Executive Officer) Buy 60,039 shares, Mazzariello Gina (Chief Legal Officer) Buy 21,284 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-08-20FRATES JAMES MChief Financial OfficerBuy22,807$0
2026-08-20Bedrosian Camille LChief Medical OfficerBuy22,807$0
2026-08-20Klee Justin B.Co-Chief Executive OfficerBuy60,039$0
2026-08-20Cohen Joshua BCo-Chief Executive OfficerBuy60,039$0
2026-08-20Mazzariello GinaChief Legal OfficerBuy21,284$0
2026-07-13Mazzariello GinaChief Legal OfficerSell15,000$274,746
2026-07-13Mazzariello GinaChief Legal OfficerSell15,000$264,122
2026-05-26Firestone KarenDirectorBuy3,800$51,338
2026-03-09Cohen Joshua BCo-Chief Executive OfficerBuy248,865$0
2026-03-09Bedrosian Camille LChief Medical OfficerBuy95,990$0
2026-03-09Mazzariello GinaChief Legal OfficerBuy74,660$0
2026-03-09Klee Justin B.Co-Chief Executive OfficerBuy248,865$0
2026-03-09FRATES JAMES MChief Financial OfficerBuy95,990$0
2026-03-04Mazzariello GinaChief Legal OfficerSell6,844$99,375
2026-03-04Cohen Joshua BCo-Chief Executive OfficerSell29,282$424,003
2026-03-04Klee Justin B.Co-Chief Executive OfficerSell29,282$423,711
2026-03-04FRATES JAMES MChief Financial OfficerSell7,909$114,839
2026-03-04Bedrosian Camille LChief Medical OfficerSell6,461$94,201
2026-02-25Mazzariello GinaChief Legal OfficerSell3,419$48,345
2026-02-04FRATES JAMES MChief Financial OfficerSell3,557$52,110
2026-02-04Cohen Joshua BCo-Chief Executive OfficerSell15,500$227,540
2026-02-04Klee Justin B.Co-Chief Executive OfficerSell15,500$227,695
2026-02-04Mazzariello GinaChief Legal OfficerSell3,448$50,513
2026-01-20Cohen Joshua BCo-Chief Executive OfficerBuy197,182$1.5M
2026-01-20Cohen Joshua BCo-Chief Executive OfficerSell136,193$1.9M

Source: SEC Form 4 filings · as of 2026-08-20